ZOETIS

ZTS

182.380
USD
2.3
(1.28%)
Market Open
Volume
3,533
EPS
0
Div Yield
0
P/E
37
Market Cap
85,418,233,655
Signals
buy
ZTS@174.98
2024-07-08 08:45
Profit
267
Related Instruments
BDX
-4.995
(-2.07%)
236.055 USD
H
HSIC
0.860
(1.20%)
72.790 USD
I
IDXX
1.95
(0.41%)
477.81 USD
LLY
28.47
(3.54%)
832.74 USD
MCK
11.85
(1.92%)
628.90 USD
MNST
-0.080
(-0.16%)
51.370 USD
P
PDCO
0.010
(0.04%)
25.270 USD
PFE
0.115
(0.38%)
30.650 USD
ZTS
2.300
(1.28%)
182.380 USD
News

Title: ZOETIS

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.